ES2981006T3 - Pirazoloazepin-4-onas sustituidas y su uso como inhibidores de la fosfodiesterasa - Google Patents

Pirazoloazepin-4-onas sustituidas y su uso como inhibidores de la fosfodiesterasa Download PDF

Info

Publication number
ES2981006T3
ES2981006T3 ES17811328T ES17811328T ES2981006T3 ES 2981006 T3 ES2981006 T3 ES 2981006T3 ES 17811328 T ES17811328 T ES 17811328T ES 17811328 T ES17811328 T ES 17811328T ES 2981006 T3 ES2981006 T3 ES 2981006T3
Authority
ES
Spain
Prior art keywords
tetrahydropyran
spiro
oxo
dihydro
pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17811328T
Other languages
English (en)
Spanish (es)
Inventor
Xifu Liang
Jens Larsen
Simon Feldbæk Nielsen
Peter Andersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Union Therapeutics AS
Original Assignee
Union Therapeutics AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Therapeutics AS filed Critical Union Therapeutics AS
Application granted granted Critical
Publication of ES2981006T3 publication Critical patent/ES2981006T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES17811328T 2016-12-12 2017-12-12 Pirazoloazepin-4-onas sustituidas y su uso como inhibidores de la fosfodiesterasa Active ES2981006T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16203335 2016-12-12
PCT/EP2017/082424 WO2018108910A1 (en) 2016-12-12 2017-12-12 Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors

Publications (1)

Publication Number Publication Date
ES2981006T3 true ES2981006T3 (es) 2024-10-04

Family

ID=57542834

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17811328T Active ES2981006T3 (es) 2016-12-12 2017-12-12 Pirazoloazepin-4-onas sustituidas y su uso como inhibidores de la fosfodiesterasa

Country Status (7)

Country Link
US (2) US11065257B2 (cg-RX-API-DMAC7.html)
EP (1) EP3551632B1 (cg-RX-API-DMAC7.html)
JP (1) JP7008073B2 (cg-RX-API-DMAC7.html)
CN (1) CN110167944B (cg-RX-API-DMAC7.html)
ES (1) ES2981006T3 (cg-RX-API-DMAC7.html)
RU (1) RU2768746C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018108910A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018286964B2 (en) 2017-06-20 2022-04-14 UNION therapeutics A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2019115776A1 (en) 2017-12-15 2019-06-20 Leo Pharma A/S Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803299B1 (fr) * 2000-01-05 2004-09-17 Warner Lambert Co NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
US7423031B2 (en) 2003-05-01 2008-09-09 Irm Llc Compounds and compositions as protein kinase inhibitors
AR058071A1 (es) * 2005-10-03 2008-01-23 Astrazeneca Ab Derivados de dihidropirazolo (3,4-e)(1,4)diazepina. procesos de obtencion y composiciones farmaceuticas.
WO2007115232A2 (en) * 2006-03-30 2007-10-11 Chemocentryx, Inc. Cxcr4 modulators
CA2669886A1 (en) * 2006-11-15 2008-05-22 Vertex Pharmaceuticals Incorporated Compounds useful as protein kinase inhibitors
PL2114951T3 (pl) * 2007-02-28 2014-10-31 Leo Pharma As Nowe inhibitory fosfodiesterazy
GB0704652D0 (en) 2007-03-09 2007-04-18 Syngenta Participations Ag Novel herbicides
WO2011003005A1 (en) * 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
CN110088108B (zh) * 2016-12-12 2024-06-14 联合疗法公司 取代的吡唑并氮杂䓬-4-酮类及其作为磷酸二酯酶抑制剂的用途
ES2874632T3 (es) * 2016-12-12 2021-11-05 Union Therapeutics As Pirazoloazepin-8-onas sustituidas y su uso como inhibidores de la fosfodiesterasa

Also Published As

Publication number Publication date
CN110167944B (zh) 2024-08-23
US11065257B2 (en) 2021-07-20
RU2768746C2 (ru) 2022-03-24
WO2018108910A1 (en) 2018-06-21
RU2019121694A (ru) 2021-01-12
JP7008073B2 (ja) 2022-01-25
EP3551632B1 (en) 2024-06-12
US20220362259A1 (en) 2022-11-17
CN110167944A (zh) 2019-08-23
EP3551632C0 (en) 2024-06-12
JP2020511410A (ja) 2020-04-16
US20200323869A1 (en) 2020-10-15
EP3551632A1 (en) 2019-10-16
RU2019121694A3 (cg-RX-API-DMAC7.html) 2021-01-21

Similar Documents

Publication Publication Date Title
ES2972419T3 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
ES2584055T3 (es) Compuestos heterocíclicos de benzodioxol o benzodioxepina como inhibidores de la fosfodiesterasa
ES2968822T3 (es) Azetidina dihidrotienopirimidinas sustituidas y su uso como inhibidores de la fosfodiesterasa
US11866445B2 (en) Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
EP2404922B1 (en) Quinoxaline compounds
ES2973661T3 (es) Compuestos de cetona bicíclica y procedimientos de uso de los mismos
ES2968824T3 (es) Tetrahidropirano dihidrotienopirimidinas sustituidas y su uso como inhibidores de la fosfodiesterasa
WO2015178955A1 (en) Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitors
ES2935615T3 (es) Azetidina dihidrotienopiridinas sustituidas y su uso como inhibidores de la fosfodiesterasa
CA3163933A1 (en) Antagonists of the muscarinic acetylcholine receptor m4
KR20230039701A (ko) 무스카린성 아세틸콜린 수용체 m4의 양성 알로스테릭 조절제로서의 7-(피페리딘-1-일)-4h-피리미도[1,2-b]피리다진-4-온 유도체
ES2991955T3 (es) Antagonistas del receptor muscarínico de la acetilcolina M4
ES2875128T3 (es) Pirazoloazepin-8-onas sustituidas y su uso como inhibidores de la fosfodiesterasa
TWI924832B (zh) Abhd6拮抗劑
WO2022135390A1 (zh) 己酮糖激酶抑制剂及其用途
US20220362259A1 (en) Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
ES2874632T3 (es) Pirazoloazepin-8-onas sustituidas y su uso como inhibidores de la fosfodiesterasa
CA3231925A1 (en) Fused heterocyclic rings as ripk1 inhibitors
CN104387358A (zh) 淫羊藿苷类化合物及其应用
RU2817698C2 (ru) Замещенные дигидротиенопиримидины и их применение в качестве ингибиторов фосфодиэстеразы
RU2797922C2 (ru) Бициклические кетоны и способы их применения
CN122070282A (zh) 作为rip1激酶抑制剂的吡唑-1-羧酰胺